Dharna Gupta

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Psychometric Properties

Small Cell Lung Cancer

Top Venues

JCO global oncology

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Applied health economics and health policy

This page only lists publications with an associated author ORCID identifier.

Publications

Dharna Gupta, Nidhi Gupta, Navneet Singh, Shankar Prinja
Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. JCO global oncology 10 (2024)
Dharna Gupta, Nidhi Gupta, Navneet Singh, Shankar Prinja
Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. JCO global oncology 10 (2024)
Dharna Gupta, Nidhi Gupta, Navneet Singh, Shankar Prinja
Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. JCO global oncology 10 (2024)
Anuradha Sharma, Shankar Prinja, Ravinder Thakur, Dharna Gupta, Rajwinder Kaur, Sameer Sharma, Sanjay Munjal, Naresh Kumar Panda
Healthcare Cost of Cochlear Implantation in India. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 76 (2) (2023)
Anuradha Sharma, Shankar Prinja, Ravinder Thakur, Dharna Gupta, Rajwinder Kaur, Sameer Sharma, Sanjay Munjal, Naresh Kumar Panda
Healthcare Cost of Cochlear Implantation in India. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 76 (2) (2023)
Nidhi Gupta, Dharna Gupta, Jyoti Dixit, Nikita Mehra, Ashish Singh, Manjunath Nookala Krishnamurthy, Sushmita Ghoshal, Kavitha Rajsekhar, Jayachandran Perumal Kalaiyarasi, Partha Sarathi Roy, Prabhat Singh Malik, Anisha Mathew, Pankaj Malhotra, Sudeep Gupta, Lalit Kumar, Amal Kataki, Shankar Prinja
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women. Applied health economics and health policy 20 (4) (2022)